Effect of Resveratrol Supplementation on Exercise Performance and Recovery
Part of paid clinical trials in Orlando, Florida.
- Sponsor
- University of Central Florida
- Study ID
- NCT06723119
- Status
- Recruiting
Conditions
- Effect of Resveratrol on Performance and Recovery
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Accepted
Interventions
- Resveratrol (VRES) 500 mg oral once daily. — OTHERResveratrol supplement will be provided in capsule form within a distinctly labeled bottle. Participants will be instructed to consume 2 capsules (500mg) of their assigned supplement with at least 8oz of water immediately upon waking for 17 days.
- Placebo 500 mg oral once daily. — OTHERPlacebo will be supplement will be provided in capsule form within a distinctly labeled bottle. Participants will be instructed to consume 2 capsules (500mg) of their assigned supplement with at least 8oz of water immediately upon waking for 17 days.
Study Details
To examine the effects of once daily supplementation with 500mg VeriSperse® resveratrol (VRES) for 17 days on muscle function, delayed onset muscle soreness, systemic concentrations of muscular damage markers and markers of oxidative stress in resistance trained young adult males following a damaging isoinertial squat protocol (ISP).
Key Dates
- Start date
- Oct 1, 2024
- Status verified
- Nov 2024
- Primary completion
- Apr 1, 2025
- Completion
- Apr 1, 2025
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Active Comparator: Resveratrol SupplementationOnce daily (immediately upon waking) supplementation with 500mg (2 capsules) VeriSperse® resveratrol (VRES) for 17 days
- Placebo Comparator: PlaceboOnce daily (immediately upon waking) supplementation with 500mg (2 capsules) Placebo (maltodextrin) for 17 days
Primary Outcome Measure
Venous Blood Sample Collection - Creatine Kinase [ Time Frame: Visit 2 & visits 6-13 approx=8 weeks ]
Central Contacts
- Trevor Dufner701-205-8690
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Central Florida EPIC Lab | Orlando | Florida | 32816 | Trevor Dufner (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Orlando, FL
By research site